文献速递胰腺与胆道疾病消化内镜

超声内镜引导下顺行介入治疗外科改变解剖患者的良性胆道疾病(附视频)

EUS-guided antegrade intervention for benign biliary diseases in patients with surgically altered anatomy (with videos).
PubMed 文献 · Gastrointest Endosc · 2018-08-01

本研究回顾性分析37例外科改变解剖且球囊小肠镜辅助ERCP失败的良性胆道疾病患者,接受超声内镜引导下顺行介入治疗。超声内镜建立肝肠通道技术成功率为91.9%(34/37),中重度不良事件发生率为8.1%(胆管性腹膜炎3例),最终临床成功率为91.9%。作者认为该技术是BE-ERCP失败后可考虑的安全替代方法。

要点

  • 超声内镜建立肝肠通道技术成功率为91.9%(34/37)
  • 中重度不良事件发生率为8.1%,均为胆管性腹膜炎(3例)
  • 最终临床成功率为91.9%,作者认为该技术可行且安全

核心结论

  • 对于外科改变解剖的良性胆道疾病患者,球囊小肠镜辅助ERCP失败后,超声内镜引导下顺行介入治疗似乎是可行的安全替代方法。

研究设计与样本

  • 回顾性研究,纳入2013年11月至2017年11月期间37例外科改变解剖且球囊小肠镜辅助ERCP失败的良性胆道疾病患者,均接受超声内镜引导下顺行介入治疗。

主要发现

  • 超声内镜建立肝肠通道的总体技术成功率为91.9%(34/37)。
  • 中重度不良事件发生率为8.1%,均为胆管性腹膜炎(3例)。
  • 一期超声内镜引导下顺行介入治疗8例(100%)成功,且无不良事件。
  • 另26例在约1或2个月后行二期ERCP引导下顺行介入治疗,其中透视下内镜顺行治疗成功6例,需经口胆道镜辅助顺行介入19例(导丝通过吻合口狭窄6例,胆道镜引导下电动液压碎石13例),1例行磁压吻合术。
  • 所有超声内镜引导下顺行介入治疗的最终临床成功率为91.9%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Although balloon enteroscopy-assisted ERCP (BE-ERCP) is effective and safe for benign biliary diseases in patients with surgically altered anatomy (SAA), BE-ERCP is not always successful. Recently, EUS-guided antegrade intervention (EUS-AI) by using a 1-stage or 2-stage procedure has been developed for BE-ERCP failure cases. The aim of the present study was to evaluate the outcome of EUS-AI for benign biliary diseases in patients with SAA. METHODS: Of 48 patients in whom BE-ERCP failed, percutaneous transhepatic intervention was performed in 11. From November 2013 until November 2017, we retrospectively reviewed cases of an additional 37 patients with SAA who failed BE-ERCP and underwent EUS-AI for benign biliary diseases (common bile duct stones [n = 11], intrahepatic bile duct stones [n = 5], anastomotic strictures [n = 21]). RESULTS: The overall technical success of the creation of the hepatoenteric tract by EUS was 91.9% (34/37). Moderate adverse events were observed in 8.1% (biliary peritonitis [n = 3]). One-stage EUS-AI by EUS succeeded in 8 cases (100%) without any adverse events. In another 26 cases, 2-stage EUS-AI by ERCP was performed about 1 or 2 months later. Endoscopic antegrade therapy under fluoroscopy was successful in 6 cases. Per-oral cholangioscopy-assisted antegrade intervention was required in 19 cases (guidewire manipulation across the anastomotic stricture [n = 6], cholangioscopy-guided lithotripsy by using electrohydraulic lithotripsy [n = 13]). In 1 case, magnetic compression anastomosis was performed. The final clinical success rate of all EUS-AIs was 91.9%. CONCLUSIONS: EUS-AI for benign biliary diseases in patients with SAA appears to be a feasible and safe alternative procedure after BE-ERCP failure.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Mukai S, Itoi T, Sofuni A, et al. EUS-guided antegrade intervention for benign biliary diseases in patients with surgically altered anatomy (with videos). Gastrointest Endosc. 2018. PMID: 30076841. doi:10.1016/j.gie.2018.07.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。